Cancer Family
Respiratory System Neoplasm
CI-CAN-00000049Explore in graph →
Non-malignant2,727 active trials51 approved drugs619 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000049Explore in graph →
Clinical trials
11,614 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02795884 | Adjuvant Erlotinib Intercalating Chemotherapy or Adjuvant Chemotherapy Alone in NSCLC With Common EGFR Mutation | withdrawn | Phase 3 | 0 | Yonsei UniversityOTHER | 0 | Dec 30, 2016 | clinicaltrials |
| NCT02029209 | To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer | unknown | Phase 2 / Phase 3 | 110 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY |
| 1 |
| Dec 16, 2016 |
| clinicaltrials |
| NCT02988635 | Early Palliative Care on Quality of Life of Advanced Cancer Patients | completed | Phase 3 | 281 | Azienda Ospedaliero-Universitaria di ParmaOTHER | 0 | Dec 9, 2016 | clinicaltrials |
| NCT00040885 | Docetaxel With or Without Infliximab in Treating Weight Loss, Loss of Appetite, and Fatigue in Patients With Unresectable Non-Small Cell Lung Cancer (Infliximab Treatment Discontinued Effective 10/05/05) | completed | Phase 3 | 67 | Alliance for Clinical Trials in OncologyOTHER | 1 | Dec 7, 2016 | clinicaltrials |
| NCT01377376 | A Phase 3, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 Plus Erlotinib Versus Placebo Plus Erlotinib(ATTENTION) | terminated | Phase 3 | — | Kyowa Kirin Co., Ltd.INDUSTRY | 1 | Dec 7, 2016 | clinicaltrials |
| NCT01631565 | Early Incorporation of Patient and Family to Attention and Care Program in Oncology Versus Standard of Care(PACO) | completed | Phase 3 | 201 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Nov 25, 2016 | clinicaltrials |
| NCT02972333 | Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M | unknown | Phase 3 | 150 | Shandong Cancer Hospital and InstituteOTHER | 0 | Nov 23, 2016 | clinicaltrials |
| NCT00806923 | A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 1,044 | Hoffmann-La RocheINDUSTRY | 20 | Nov 2, 2016 | clinicaltrials |
| NCT01814553 | ADAM-Afatinib Diarrhea Assessment and Management | completed | Phase 3 | 40 | Boehringer IngelheimINDUSTRY | 1 | Oct 31, 2016 | clinicaltrials |
| NCT01015443 | Cancer Vaccine Study for Stage III, Unresectable, Non-small Cell Lung Cancer (NSCLC) in the Asian Population(INSPIRE) | terminated | Phase 3 | 285 | Merck KGaA, Darmstadt, GermanyINDUSTRY | 5 | Oct 26, 2016 | clinicaltrials |
| NCT02579564 | Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC Patients | unknown | Phase 3 | 134 | Xinqiao Hospital of ChongqingOTHER | 0 | Oct 21, 2016 | clinicaltrials |
| NCT02938546 | 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study | unknown | Phase 3 | 200 | Shanghai Chest HospitalOTHER | 0 | Oct 21, 2016 | clinicaltrials |
| NCT02267096 | Lombardi Comprehensive Cancer Center/Legacy Pilot Study to Reduce Adverse Smoking Outcomes in the Context of Lung Cancer Screening | completed | Phase 3 | 95 | Georgetown UniversityOTHER | 1 | Oct 19, 2016 | clinicaltrials |
| NCT00683514 | Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer | completed | Phase 3 | 201 | Pierre Fabre MedicamentINDUSTRY | 1 | Oct 4, 2016 | clinicaltrials |
| NCT00312377 | ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer(ZODIAC) | completed | Phase 3 | 1,690 | Genzyme, a Sanofi CompanyINDUSTRY | 25 | Sep 30, 2016 | clinicaltrials |
| NCT00404924 | ZD6474 (ZACTIMA™) Phase III Study in EGFR Failures | completed | Phase 3 | 1,140 | Genzyme, a Sanofi CompanyINDUSTRY | 22 | Sep 30, 2016 | clinicaltrials |
| NCT00132613 | Trial of Drainage With or Without Bleomycin Instillation for Malignant Pericardial Effusion | completed | Phase 3 | 80 | Japan Clinical Oncology GroupOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00144989 | A Study Comparing Irinotecan and Cisplatin (IP) With Etoposide and Cisplatin (EP) Following EP/TRT for LD-SCLC | completed | Phase 3 | 281 | Haruhiko FukudaOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT02360761 | Surgical Treatment of Elderly Patients With cT1N0M0 Non-small Cell Lung Cancer Comparison Between Sublobar Resection and Lobectomy(STEPS) | unknown | Phase 3 | 339 | Peking University People's HospitalOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT02906280 | RCT Comparing 19Ga vs 22Ga EBUS-TBNA Needles in Carcinoma. | unknown | Phase 3 | 78 | KU LeuvenOTHER | 1 | Sep 20, 2016 | clinicaltrials |
| NCT00035152 | Study Comparing Weekly Taxol and Carboplatin vs Standard Taxol and Carboplatin Regimen for Stage IIIB or IV Non-Small-Cell Lung Cancer | completed | Phase 3 | 444 | Bristol-Myers SquibbINDUSTRY | 1 | Sep 19, 2016 | clinicaltrials |
| NCT00190476 | Elderly NSCLC/D vs DP (JCOG0207) | terminated | Phase 3 | 230 | Japan Clinical Oncology GroupOTHER | 1 | Sep 12, 2016 | clinicaltrials |
| NCT00475098 | Effect of Low Molecular Weight Heparin: Tinzaparin in Lung Tumours (TILT)(TILT) | completed | Phase 3 | 553 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 2, 2016 | clinicaltrials |
| NCT02802540 | Nabilone Effect on the Attenuation of Anorexia, Nutritional Status and Quality of Life in Lung Cancer Patients | unknown | Phase 2 / Phase 3 | 78 | Instituto Nacional de Cancerologia de MexicoOTHER | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00357734 | Iressa Follow-up Trial | completed | Phase 3 | 14 | AstraZenecaINDUSTRY | 1 | Aug 30, 2016 | clinicaltrials |
| NCT02883543 | First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation | unknown | Phase 3 | 330 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 0 | Aug 30, 2016 | clinicaltrials |
| NCT01887795 | Phase Ⅲ Trial of WBRT Versus Erlotinib Concurrent Whole-brain Radiation Therapy as first-line Treatment for Patients With Multiple Brain Metastases From Non-small-cell Lung Cancer(ENTER): a Multicentre, Open-label, Randomised Study | completed | Phase 3 | 224 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityOTHER | 1 | Aug 25, 2016 | clinicaltrials |
| NCT02879097 | Efficacy-Safety-Immunogenicity Study of CBT124&EU-sourced Avastin® in Stage 4 NSCLC | unknown | Phase 3 | 200 | Cipla BioTec Pvt. Ltd.INDUSTRY | 0 | Aug 25, 2016 | clinicaltrials |
| NCT02875457 | Apatinib as the Maintenance Therapy for Extensive Stage Small Cell Lung Cancer After Combined With Etoposide/Cisplatin | unknown | Phase 3 | 100 | Third Military Medical UniversityOTHER | 0 | Aug 24, 2016 | clinicaltrials |
| NCT00826683 | Detection of Circulating Endothelial Progenitors Cells (EPCs) in Non-small Cell Lung Cancer (NSCLC)(CBNPC:PCE) | completed | Phase 3 | 140 | University Hospital, LimogesOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT02859077 | EGFR-TKI With Chemotherapy in NSCLC Patients With Both EGFR Mutation and BIM Deletion Polymorphism | unknown | Phase 3 | 100 | Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER | 0 | Aug 9, 2016 | clinicaltrials |
| NCT01460472 | Immunotherapy With Racotumomab in Advanced Lung Cancer | unknown | Phase 3 | 1,082 | Recombio SLINDUSTRY | 7 | Jul 29, 2016 | clinicaltrials |
| NCT00656136 | BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1) | completed | Phase 3 | 585 | Boehringer IngelheimINDUSTRY | 15 | Jul 26, 2016 | clinicaltrials |
| NCT00003299 | Cisplatin Plus Etoposide With or Without Paclitaxel in Treating Patients With Extensive-Stage Small Cell Lung Cancer | completed | Phase 3 | 587 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 20, 2016 | clinicaltrials |
| NCT00003387 | Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery | completed | Phase 3 | 366 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 20, 2016 | clinicaltrials |
| NCT00003831 | Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer | completed | Phase 3 | 1,023 | Alliance for Clinical Trials in OncologyOTHER | 3 | Jul 14, 2016 | clinicaltrials |
| NCT00003317 | Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Stage IIIA Non-small Cell Lung Cancer | completed | Phase 3 | 480 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00003600 | Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy | completed | Phase 3 | 344 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00003674 | Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | completed | Phase 3 | 141 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT00006349 | Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer | completed | Phase 3 | 9 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00033592 | Comparison of Nicotine Inhaler and/or Bupropion in Helping People to Stop Smoking and Prevent the Recurrence of Smoking | completed | Phase 3 | 1,708 | Alliance for Clinical Trials in OncologyOTHER | 2 | Jul 13, 2016 | clinicaltrials |
| NCT01798485 | A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC(Galaxy 2) | terminated | Phase 3 | 696 | Synta Pharmaceuticals Corp.INDUSTRY | 20 | Jul 1, 2016 | clinicaltrials |
| NCT00003117 | Paclitaxel With or Without Carboplatin in Treating Patients With Advanced Non-small Cell Lung Cancer | completed | Phase 3 | 584 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jun 30, 2016 | clinicaltrials |
| NCT00686959 | Chemotherapy and Radiation in Treating Participants With Stage 3 Non-Small Cell Lung Cancer(PROCLAIM) | completed | Phase 3 | 598 | Eli Lilly and CompanyINDUSTRY | 19 | Jun 28, 2016 | clinicaltrials |
| NCT01441752 | Efficacy Study of Integrated TCM Combined With Chemotherapy in Postoperative NSCLC Patients | completed | Phase 3 | 349 | xulingOTHER | 1 | Jun 27, 2016 | clinicaltrials |
| NCT02790190 | Individualized Adaptive Radiotherapy Based on PET/CT and IMRT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) | unknown | Phase 3 | 400 | Shandong Cancer Hospital and InstituteOTHER | 1 | Jun 3, 2016 | clinicaltrials |
| NCT00259064 | Iressa v BSC (Best Supportive Care) in First Line NSCLC(INSTEP) | completed | Phase 2 / Phase 3 | 216 | AstraZenecaINDUSTRY | 5 | Jun 2, 2016 | clinicaltrials |
Data updated 24 days agoSource updated Dec 30, 2016source: clinicaltrials